Inflammatory factors, especially IL-1β, are widely considered to be a major cause of ECM metabolic disorders, and IL-1β is commonly used to establish in vitro models of OA (Fukui et al., 2003; Caramés et al., 2008). The gene discussed is IL1B; the disease is metabolic disease.